Target intelligence / Profile preview

Myo-inositol (MI)

Target
MI
Molecular classification
Other (Sugar alcohol), Small molecule/metabolite, Precursor to: Inositol phosphate secondary messengers, phosphatidylinositol lipids, Not a receptor, enzyme, transporter, or transcription factor
01

Overview

Myo-inositol is the most stable isomer of inositol, a six-carbon cyclic sugar alcohol and a polyol (C6H12O6) found in all living cells. It is highly water-soluble and acts primarily as the structural basis for many crucial secondary messengers in eukaryotic cells, particularly inositol phosphates and lipid-derived messengers such as phosphatidylinositol and its phosphorylated derivatives (PIP lipids). These inositol-containing molecules play a pivotal role in cellular signaling, energy metabolism, membrane structure, and are involved in diverse processes such as insulin signal transduction, cell growth, apoptosis, and neurotransmission. While inositol itself is not a direct pharmacological target, enzymes involved in its metabolism (e.g., inositol monophosphatase targeted by lithium) and signaling derivatives are clinically relevant.

Other names
Myo-inositolCyclohexanehexoli-Inositolmeso-InositolDamboseInositalInositeneInositinaiso-InositolMeat sugarMesovitMyoinositeMIPhaseomanniteScylliteCyclohexitolInositeMouse antialopecia factorMuscle sugarRat antispectacled eye factorHexahydroxycyclohexane
02

Mechanism of action

As a precursor: mechanism involves metabolism to signaling lipids and messengers. For *lithium*: inhibits inositol monophosphatase, reducing availability of free inositol and modulating signal transduction

03

Biological functions

Structural component of cell membrane phospholipids (phosphatidylinositol)Precursor to inositol phosphates (secondary messengers in signal transduction)Involved in lipid signaling cascadesPlays roles in insulin signaling, cytoskeleton assembly, nerve guidance, membrane potentials, serotonin activity, fat metabolism, and cholesterol reductionRequired for cell signaling, energy processing, and various cellular functions
04

Disease associations

Indirect roles implicated in:Cancer (via cell signaling)Neurodegenerative diseases (Alzheimer’s disease, Huntington’s disease, bipolar disorder, ALS, via inositol depletion and phosphoinositide signaling modulation)Metabolic disorders (diabetes, obesity via insulin signaling and energy sensing)Other disease relevance is through dysregulation of pathways that utilize inositol derivatives
05

Safety considerations

Notable safety concerns limited as it is generally regarded as safe and is found endogenouslyOveruse or misregulation implicated only indirectly via metabolic disorders and excessive signal transductionLithium toxicity involves inositol depletion but is not directly a safety issue of inositol supplementation
06

Interacting drugs

Lithium (inhibits inositol monophosphatase; basis of inositol depletion hypothesis)

1 more in the full profile.

07

Biomarkers

Not directly used as a biomarker; inositol/phosphatidylinositol and derivatives may be measured in disease contexts (e.g., psychiatric, neurodegenerative disorders, metabolic status)

Beyond the preview

Go deeper on Myo-inositol (MI).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myo-inositol (MI).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call